Adelaide Research & Scholarship: Search

Search

Results 1-9 of 9 (Search time: 0.003 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2006	Circulating steroid hormones and the risk of prostate cancer	Severi, G.; Morris, H.; MacInnes, R.; English, D.; Tilley, W.; Hopper, J.; Boyle, P.; Giles, G.
	2007	5 α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia	Hayes, V.; Severi, G.; Padilla, E.; Morris, H.; Tilley, W.; Southey, M.; English, D.; Sutherland, R.; Hopper, J.; Boyle, P.; Giles, G.
	2008	Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential	Ricciardelli, C.; Jackson, M.; Choong, C.; Stahl, J.; Marshall, V.; Horsfall, D.; Tilley, W.
	2011	Specific medical conditions associated with clinically significant depressive symptoms in men	Atlantis, E.; Lange, K.; Goldney, R.; Martin, S.; Haren, M.; Taylor, A.; O'Loughlin, P.; Marshall, V.; Tilley, W.; Wittert, G.
	2003	ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer	Severi, G.; Giles, G.; Southey, M.; Tesoriero, A.; Tilley, W.; Neufing, P.; Morris, H.; English, D.; McCredie, M.; Boyle, P.; Hopper, J.
	2006	Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer	Severi, G.; Morris, H.; MacInnis, R.; English, D.; Tilley, W.; Hopper, J.; Boyle, P.; Giles, G.
	2012	Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors	Centenera, M.; Gillis, J.; Hanson, A.; Jindal, S.; Taylor, R.; Risbridger, G.; Sutherland, P.; Scher, H.; Raj, G.; Knudsen, K.; Yeadon, T.; Tilley, W.; Butler, L.
	2006	Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA	Severi, G.; Hayes, V.; Neufing, P.; Padilla, E.; Tilley, W.; Eggleton, S.; Morris, H.; English, D.; Southey, M.; Hopper, J.; Sutherland, R.; Boyle, P.; Giles, G.
	2010	Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome	Callen, D.; Ricciardelli, C.; Butler, M.; Stapleton, A.; Stahl, J.; Kench, J.; Horsfall, D.; Tilley, W.; Schulz, R.; Nesland, J.; Neilsen, P.; Kumar, R.; Holm, R.